Definition and management of radioactive iodine-refractory differentiated thyroid cancer

被引：282
|
作者：
Schlumberger, Martin [1 ,2 ]
Brose, Marcia [3 ]
Elisei, Rosella [4 ]
Leboulleux, Sophie [1 ,2 ]
Luster, Markus [5 ]
Pitoia, Fabian [6 ]
Pacini, Furio [7 ]
机构：
[1] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France
[2] Univ Paris Sud, Villejuif, France
[3] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[4] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[5] Univ Marburg, Dept Nucl Med, Marburg, Germany
[6] Univ Buenos Aires, Hosp Clin, Div Endocrinol, Buenos Aires, DF, Argentina
[7] Univ Siena, Unit Endocrinol, I-53100 Siena, Italy
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2014年 / 2卷 / 05期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; CLINICAL-OUTCOMES; FATTY LIVER; CARCINOMA; THERAPY; PLACEBO;
D O I：
10.1016/S2213-8587(13)70215-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：356 / 358
页数：4
相关论文
共 50 条
  • [1] Challenges in the evaluation and management of radioactive iodine-refractory differentiated thyroid cancer
    Genco, Matthew T.
    Yaqub, Abid
    Jana, Suman
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (07) : 743 - 745
  • [2] Radioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly
    Rohit Gosain
    Jonathan S. Alexander
    Amitoj Gill
    Cesar Perez
    [J]. Current Oncology Reports, 2018, 20
  • [3] Radioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly
    Gosain, Rohit
    Alexander, Jonathan S.
    Gill, Amitoj
    Perez, Cesar
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (10)
  • [4] Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer
    Worden, Francis
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (06) : 267 - 279
  • [5] Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
    Liu, Jierui
    Liu, Yanqing
    Lin, Yansong
    Liang, Jun
    [J]. ENDOCRINOLOGY AND METABOLISM, 2019, 34 (03) : 215 - 225
  • [6] Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
    Volpe, Fabio
    Nappi, Carmela
    Zampella, Emilia
    Di Donna, Erica
    Maurea, Simone
    Cuocolo, Alberto
    Klain, Michele
    [J]. CURRENT ONCOLOGY, 2024, 31 (07) : 3870 - 3884
  • [7] Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer
    Capdevila, Jaume
    Newbold, Kate
    Licitra, Lisa
    Popovtzer, Axon
    Moreso, Francesc
    Zamorano, Jose
    Kreissl, Michael
    Aller, Javier
    Grande, Enrique
    [J]. CANCER TREATMENT REVIEWS, 2018, 69 : 164 - 176
  • [8] EVOLVING APPROACHES IN MANAGING RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
    Sacks, Wendy
    Braunstein, Glenn D.
    [J]. ENDOCRINE PRACTICE, 2014, 20 (03) : 263 - 275
  • [9] Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
    Schmidt, Angelica
    Iglesias, Laura
    Klain, Michele
    Pitoia, Fabian
    Schlumberger, Martin J.
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (01): : 81 - 89
  • [10] Sorafenib in metastatic radioactive iodine-refractory differentiated thyroid cancer: A pilot study
    Luo, Yang
    Shi, Yuankai
    Xing, Puyuan
    Wang, Lin
    Feng, Yun
    Han, Xiaohong
    He, Xiaohui
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 87 - 92
12345